http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0166102-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56bd87a473efe78f74785ad69cdfa286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2001-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb051a4319a6b8d7b754ad007787b7cf
publicationDate 2001-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0166102-A2
titleOfInvention Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same
abstract This invention provides a dosage form and a method of administering an anti-tumor composition comprising tegafur, uracil and folinic acid to potentiate the coadministration of oxaliplatin.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6476068-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008042075-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008042075-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6673805-B2
priorityDate 2000-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129575635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129113828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17842493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129281950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226563887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135402009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14550603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID288216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1712093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129575636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID125110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129532320
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136123990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399572
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136058681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135430812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129816239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226474706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396529

Total number of triples: 60.